Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility
Author Information
Author(s): Kazaryan Shushanik A, Oganian Seda A, Vardanyan Gayane S, Sidorenko Anatolie S, Hovhannisyan Ashkhen A
Primary Institution: Russian-Armenian (Slavonic) University
Hypothesis
This study evaluates the biocompatibility of iron oxide nanoparticles and their complexes with plant extracts on liver tissue.
Conclusion
Iron oxide nanoparticles and their complexes do not exhibit direct hepatotoxicity, but their combinations can affect liver function markers.
Supporting Evidence
- Fe3O4 nanoparticles do not show direct hepatotoxicity when administered to rats.
- All agents tested exert a hypolipidemic effect by lowering LDL cholesterol.
- Fe3O4 nanoparticles increase the activity of glutathione peroxidase in liver tissue.
Takeaway
The study looks at tiny particles that can help deliver medicine to the liver without hurting it, but when mixed with certain plants, they can cause some problems.
Methodology
The study involved administering iron oxide nanoparticles and plant extracts to healthy Wistar rats and measuring various liver function markers.
Potential Biases
Potential bias may arise from the limited sample size and specific conditions under which the experiments were conducted.
Limitations
The study primarily focuses on a specific type of nanoparticles and their effects on liver function without exploring long-term impacts.
Participant Demographics
Healthy white Wistar rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website